PRESS RELEASE. Sciety welcomes Thomas Eldered as Senior Advisor. Thomas has over 35 years of experience in the pharmaceutical industry and is co-founder of Recipharm and founder of the investment firm Flerie. His background as an entrepreneur, business leader and investor brings valuable perspectives on investments and building successful companies
PRESS RELEASE. Sciety’s Board of Directors has appointed Anna Sundin as the company’s new CEO. She succeeds one of Sciety’s founders, Andreas Lindblom, who will continue in an operational role as Managing Partner. Anna Sundin has 25 years of experience in the financial sector and joins Sciety from BearingPoint, where
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
INSIGHT. Obesity is one of the fastest-growing public health challenges of our time. More than a billion people are estimated to be living with the disease globally today, a number that is expected to keep rising. The consequences are significant for individuals, healthcare systems and society as a whole. At
